一脉阳光：影禾医脉发布全球首个基座大模型驱动的AI辅助诊断产品

Core Viewpoint - The launch of the AIR product by Shanghai Yinghe Medical Technology marks a significant advancement in medical imaging AI, transitioning from the "single disease small model" era to the "foundation large model driven" era, enabling comprehensive multi-organ diagnostic capabilities [1][2] Group 1: Product Development - The AIR product is the first commercial outcome of the Yinghe Medical's foundation large model ecosystem, designed to connect top hospitals with grassroots medical institutions through open interfaces [2] - The product focuses on chest CT scans, allowing for simultaneous detection and diagnosis of multiple organs, including the lungs, pleura, and mediastinum, covering all common diseases in that area [1][2] Group 2: Technological Innovation - AIR represents a technological innovation that enhances diagnostic efficiency and accuracy, fundamentally restructuring the development and application logic of medical imaging AI [1] - The product's ability to perform "one scan, multiple disease simultaneous diagnosis" significantly boosts the competitiveness and added value of the group's imaging center services [2] Group 3: Industry Impact - The introduction of AIR signifies a shift in the medical imaging AI industry from "single-point breakthroughs" to "systematic empowerment," evolving from a "tool assistance" model to a "diagnostic partner" model [2] - This new paradigm supports health screening, precision diagnosis, and telemedicine, promoting a transition from "single disease detection" to "comprehensive disease collaborative analysis" [2]